To include your compound in the COVID-19 Resource Center, submit it here.

New China regulations on genetic resources underscore flash point in U.S.-China tensions

Access to genomic data is becoming a flash point in geopolitical tensions between the U.S. and China as both sides are putting in place measures to restrict and scrutinize access to the data.

As a pair of Republican senators were calling for an HHS probe into CMS genetic testing payments to Chinese-linked companies on Monday, China’s state council issued regulations updating its rules

Read the full 627 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers